You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hypercholesterolemia, Autosomal Dominant, Type B

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2 Trial in Moscow (genetic,

Recruiting
  • Hypercholesterolemia, Familial
  • +25 more
  • Genetic Testing
  • +7 more
  • Moscow, Russian Federation
    National Medical Research Centre for Therapy and Preventive Medi
Jul 25, 2022

Autosomal Dominant Hypocalcemia (ADH) Trial run by the (CLTX-305)

Active, not recruiting
  • Autosomal Dominant Hypocalcemia (ADH)
  • Bethesda, Maryland
    National Institute of Health
Jul 20, 2022

Familial Hypercholesterolemia - Heterozygous Trial in Paris (CAC Score)

Completed
  • Familial Hypercholesterolemia - Heterozygous
  • CAC Score
  • Paris, France
    Hôpital Pitié-Salpêtrière
Sep 9, 2021

Autosomal Dominant Hypocalcemia (ADH) Trial in Greenville (Encaleret, Calcium supplements and active Vitamin D (calcitriol,

Recruiting
  • Autosomal Dominant Hypocalcemia (ADH)
  • Encaleret
  • Calcium supplements and active Vitamin D (calcitriol, alfacalcidol, falecalcitriol, etc.)
  • Greenville, North Carolina
    Physicians East
Jan 9, 2023

Nicotinamide Adverse Reaction Trial (Nicotinamide)

Not yet recruiting
  • Nicotinamide Adverse Reaction
  • (no location specified)
Aug 29, 2023

Polycystic Kidney, Autosomal Dominant Trial in United States (KD019 (tesevatinib))

Completed
Has Results
  • Polycystic Kidney, Autosomal Dominant
  • Los Angeles, California
  • +10 more
Oct 12, 2022

Hypercholesterolemia Trial in France, United States (Alirocumab, Placebo)

Completed
Has Results
  • Hypercholesterolemia
  • Salt Lake City, Utah
  • +3 more
Jun 4, 2020

Autosomal Dominant Polycystic Kidney Trial in Melbourne (AL01211 or Placebo (Part A), AL01211 or Placebo (Part B))

Active, not recruiting
  • Autosomal Dominant Polycystic Kidney
  • AL01211 or Placebo (Part A)
  • AL01211 or Placebo (Part B)
  • Melbourne, Victoria, Australia
    Nucleus Network
May 16, 2022

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trial in Worldwide (Phase A Tolvaptan, Placebo Phase A, Phase B Tolvaptan)

Completed
  • Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • Phase A Tolvaptan
  • +2 more
  • Gent, Oost-Vlaanderen, Belgium
  • +19 more
Jan 4, 2022

Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

Recruiting
  • Rare Disorders
  • +309 more
    • Sioux Falls, South Dakota
    • +1 more
    Jun 20, 2022

    Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

    Recruiting
    • Adenine Phosphoribosyltransferase Deficiency
    • +83 more
      • Bristol, South West, United Kingdom
        Zoe Plummer
      Sep 26, 2023

      Polycystic Kidney Disease, Autosomal Dominant Trial in United States (RGLS4326)

      Completed
      • Polycystic Kidney Disease, Autosomal Dominant
      • La Mesa, California
      • +11 more
      Dec 14, 2021

      Homozygous Familial Hypercholesterolemia Trial in Beijing (IBI306)

      Active, not recruiting
      • Homozygous Familial Hypercholesterolemia
      • IBI306
      • Beijing, China
        Beijing Anzhen Hospital, Capital Medical University
      Sep 12, 2022

      Heterozygous Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia Trial in Auckland,

      Recruiting
      • Heterozygous Familial Hypercholesterolemia
      • +2 more
      • Auckland, New Zealand
      • +1 more
      Aug 4, 2022

      Autosomal Dominant Osteopetrosis Type 2 Trial in Indianapolis (ACTIMMUNE)

      Completed
      Has Results
      • Autosomal Dominant Osteopetrosis Type 2
      • Indianapolis, Indiana
        Indiana University School of Medicine
      Dec 11, 2020

      Hereditary Spastic Paraplegia, Hereditary, Spastic Paraplegia, Autosomal Dominant Trial in Tübingen (other, behavioral,

      Recruiting
      • Hereditary Spastic Paraplegia
      • Hereditary, Spastic Paraplegia, Autosomal Dominant
      • SPRS Score and clinical signs
      • +6 more
      • Tübingen, Germany
        University Hospital Tübingen, Center for Neurology
      Aug 18, 2022

      Familial Hypercholesterolemia, Familial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein B, Familial

      Recruiting
      • Familial Hypercholesterolemia
      • +7 more
      • Research-based genetic test for Familial Hypercholesterolemia
      • Vancouver, British Columbia, Canada
      • +1 more
      Jan 31, 2022

      IgA Nephropathy, CKD Associated With Type 1 Diabetes, Focal Segmental Glomerulosclerosis Trial in United States (Bardoxolone

      Completed
      Has Results
      • IgA Nephropathy
      • +3 more
      • Bardoxolone methyl capsules
      • Birmingham, Alabama
      • +29 more
      Mar 15, 2022

      Polycystic Kidney, Autosomal Dominant Trial in Worldwide (Venglustat GZ402671, Placebo)

      Terminated
      Has Results
      • Polycystic Kidney, Autosomal Dominant
      • Birmingham, Alabama
      • +94 more
      Feb 1, 2023

      CLARIFY: ADH1 and ADH2 Disease Monitoring Study (DMS)

      Recruiting
      • Autosomal Dominant Hypocalcemia
        • Indianapolis, Indiana
        • +14 more
        Dec 6, 2022

        Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

        Not yet recruiting
        • Autosomal Dominant Optic Atrophy
        • +3 more
          • Sydney, Australia
            Sydney Eye Hospital
          Nov 15, 2023

          The Rogosin Institute Homozygous Familial Hypercholesterolemia

          Recruiting
          • Homozygous Familial Hypercholesterolemia
            • New York, New York
              The Rogosin Institute, Weill Cornell Medical College
            Feb 28, 2022

            Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)

            Active, not recruiting
            • Homozygous Familial Hypercholesterolemia
            • Evanston, Illinois
            • +11 more
            Jul 13, 2022

            Familial Hypercholesterolemia Trial in Worldwide (Evolocumab)

            Completed
            Has Results
            • Familial Hypercholesterolemia
            • Evolocumab
            • Bronx, New York
            • +45 more
            Dec 16, 2021

            Baby Detect : Genomic Newborn Screening

            Recruiting
            • Congenital Adrenal Hyperplasia
            • +126 more
              • Liege, Wallonia, Belgium
                CRMN, Hôpital La Citadelle
              Jan 24, 2023